Imago Biosciences Inc (IMGO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IMGO Annual Balance Sheets →
A period-by-period view of the balance sheet from Imago Biosciences Inc to Sep 30 2021 helps clarify how Sep 30 2022's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2022)
(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Assets
Cash & cash equivalent7.29
Combined Cash+Investments Total (filer-reported)-
Short-term Investments, Total171.12
Cash & Short-term Investments178.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.63
Total Current Assets182.04
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent4.00
Total Assets186.46
Liabilities
Accounts Payable, Current AC3.90
Accrued Liabilities, Current AC3.12
Total Current Liabilities13.84
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Accrued Research And Development Current6.82
Total Liabilities13.84
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock333.00
Retained Earnings / Accumulated Deficit-159.56
Other Equity-0.82
Common Stockholder's Equity172.62
Total Stockholder's Equity172.62
Liabilities & Stockholder's Equity186.46
4 historic quarters locked

Sign in to unlock the full Imago Biosciences Inc balance sheet history.

About Imago Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-22-023883

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License